Active ingredientNilvadipineCat. No. P-N065-001CAS 75530-68-6Family · Pharmaceutical analytical standards
Nilvadipine
A dihydropyridine calcium channel blocker developed in Japan, where it was approved in 1989 for hypertension; it is also used for chronic occlusion of the major cerebral arteries. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It was also put to the test against Alzheimer's disease, in a large European trial led by Trinity College Dublin with more than 500 patients, whose results, published in 2018, showed no clear benefit.
Go to the active ingredient →Active ingredientNilvadipineCat. No. P-N065-001CAS 75530-68-6
Isotopically labelledNilvadipine-d4Cat. No. P-N065-002CAS 2928067-26-7
ImpurityNilvadipine Impurity 1Cat. No. P-N065-003No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.